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COVID-19 is becoming a greatest threat to the 
humanity  and   civilization  by  every passing day from  
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the beginning of year 2020. Health organizations 
across globe are performing exhaustive teamwork and 
research to control its spread and illness. In late 
December 2019, China reported a cluster of 
pneumonia cases with unknown etiology in the 
people of Wuhan.[1],[2] The pathogen is a novel corona 
virus named Severe Acute Respiratory Syndrome 
Corona Virus 2 (SARS - CoV-2), which belongs to the 
same family of viruses responsible for Severe Acute 
Respiratory Syndrome (SARS) and Middle East 
Respiratory Syndrome (MERS) epidemics in the last 
two decades.[3] WHO described the onset of a 
potential Coronavirus outbreak and given the 
estimate of a reproduction number for the 2019 
Novel (New) Coronavirus (COVID-19, name given by 
WHO on 11 Feb, 2020).[1-4] It is known that the novel 
A B S T R A C T  
Background: The outbreak of Coronavirus disease (COVID-19) has been recently declared as Public Health 
Emergency of International Concern (PHEIC) by World Health Organization and the virus has now spread beyond 
the boundaries of countries and continents. At present, no specific antiviral treatment or vaccine is available or 
recommended to counter the COVID-19, and the potential therapy is still symptomatic. Objective: The primary 
aim of the study is to review ancient classical literatures and past human treatment protocols of Ayurveda for 
prevention and treatment of infectious diseases and flu like illnesses, so as to provide guidance for the prevention 
of COVID-19. Methods: Classical Ayurveda and recent modern literature with treatment protocols of Ayurveda for 
prevention and treatment of flu and infectious diseases were reviewed and COVID-19 has been categorized in four 
specific situations based on the severity of clinical condition. Total 110 Ayurveda practitioners of different parts of 
India were participated in the survey. These specific situations were conveyed and described to these participants 
and their opinions and options were collected through social media platform i.e. WhatsApp or SMS. Results: 
Recommendation and suggestions received from more than 50% participants were taken into accounts to draft the 
recommendation for probable preventive and therapeutic regimen for the disease. Conclusion: The results 
obtained in the study may provide a preventive strategy to the Ayurveda practitioners as well as common people 
across the globe by increasing the innate immunity of the body to combat COVID-19. However, till today, social 
distancing is considered as most effective way to stop the spread of COVID-19.  Further, pilot study for different 
group is recommended.   
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coronavirus invades human cells through its surface 
spike proteins which attaches to the angiotensin-
converting enzyme-2 (ACE-2) receptor on the surface 
of a host cell. The ACE-2 is like a "knob on door" or 
ridge and the virus "hijacks" the "knob" using its spike 
protein, facilitating the opening the door into human 
cells.[5] 
As the COVID-19 outbreak continues to spread in 
different part of the world, knowledge about its 
pathogenesis, etiology, behaviour and management is 
also increasing every day. Results of published 
epidemiological and virological studies provides 
evidence that COVID-19 is mainly transmitted from 
symptomatic people to others, having close contact 
through respiratory droplets, by direct contact with 
infected persons, or by touching contaminated 
surfaces and objects.[6] The incubation period for 
COVID-19, which is the time between exposure with 
the virus and symptom onset, is on average 5-14 days. 
During this period, patients can be pre-symptomatic 
but can be contagious.[4-7] The common signs of 
corona virus infection include flu-like, respiratory 
symptoms, fever, fatigue, cough, shortness of breath, 
breathing difficulties, while severe conditions may 
causes pneumonia, acute respiratory syndrome, acute 
cardiac injury, kidney failure, multi organ failure and 
even death.[7]  Patients of COVID-19 can be with 
nausea, cough, chills, respiratory symptoms and high 
temperature is not a general presentation in the early 
stages of infection. Elevated level of C-reactive 
protein (CRP) lymphopenia and impaired immunity 
are important characteristics for COVID-19. A cytokine 
profile resembling secondary haemophagocytic 
lymphohistiocytosis (sHLH) is associated with COVID-
19 disease severity, characterised by increased 
interleukin (IL)-2, IL-7, granulocyte-colony stimulating 
factor, interferon-γ inducible protein 10, monocyte 
chemo attractant protein 1, macrophage 
inflammatory protein 1-α, and tumour necrosis factor-
α. All these factors suggests cytokine storm and 
immunosupression.[6] Researchers are developing 
various rapid molecular and serological laboratory 
investigations for diagnosis of COVID-19 infection. At 
present, real-time reverse-transcription polymerase 
chain reaction (rRT- PCR) based molecular assay tests 
are being used to detect viral RNA load in clinical 
samples of COVID-19 subjects. In rare serological 
tests, enzyme-linked immune-sorbent assay (ELISA), is 
also considered as a screening test used to detect the 
presence and concentration of specific antibodies that 
bind to this viral protein. However, serological 
investigation is only for surveillance or investigational 
purposes and still it is not considered for diagnostic 
purposes.[4-7] 
At present, no specific antiviral treatment or vaccine is 
available or recommended to counter the COVID-19, 
and the potential therapy is still symptomatic. Oxygen 
therapy represents the major treatment intervention 
for patients with severe COVID-19 infection. The 
primary difficulty in treating COVID-19 is to combat 
the over reaction of the immune system, which 
damages lungs and its links for multiple organ failure. 
Studies suggests that mechanical ventilators may be 
necessary in cases of respiratory failure refractory to 
oxygen therapy and  hemodynamic support is of 
upmost importance for managing septic shock.[8] The 
clinical studies proved  that Traditional Chinese 
Medicine (TCM)  can alleviate symptoms of mild and 
moderate COVID-19. The severe patients suffering 
from hypoxia, can able to ease symptoms, including 
fever, coughing and shortness of breath.[9] Studies 
also suggests that baicalin in Scutellaria baicalensis, a 
TCM herbal ingredient and hesperetin in dried 
tangerine peel can combine with ACE-2, thus serving 
as a potent chemical compound for COVID-19.[10],[11] 
Xuebijing Injection, a TCM medicine, also suggested a 
significant result in lowering the risk of community-
acquired pneumonia and reduce the time ventilators 
use time of severe patients and their stay in the 
ICU.[12] 
The first case of the COVID-19 infection in India was 
reported from Kerala State on 30th January 2020, in 
passengers travelled from China and medical 
fraternity including AYUSH  practitioners been put on 
high alerts to stop its further propagation and 
management. AYUSH sector with its classical 
knowledge has a long tradition of keeping the nation 
healthy and its role has increased manifold in the 
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ongoing efforts to tackle COVID-19. The government 
through its regulatory bodies, policy makers and 
research councils emphasized the importance of 
countering and fact checking the claims of AYUSH 
having prevention and treatment for the disease and 
requested to come together for evidence based 
research. Historically, it is well known that whenever 
there is outbreak of any flu like illness or viral 
infection in India, Ayurveda principles and its 
approaches including oral administration of 
preventive drugs, herbs, formulae, decoction, indoor 
herbal medicine fumigation, etc. were recommended 
for effective prevention and treatment. Research 
Councils under the Ministry of AYUSH, Government of 
India have also issued advisory based on the Indian 
traditional medicine practices i.e. Ayurveda, 
Homeopathy and Unani before the outbreak in 
India.[13] Therefore, it is necessary to review of ancient 
classics of Ayurveda and previous human studies on 
infectious diseases and flue like illnesses to draft 
protocols for prevention and treatment of COVID-19. 
Since, Vedic period, ancient Ayurveda practitioners 
and health philosophers were aware of the existence 
of microorganisms as well as the causation of 
infectious diseases by them.[14] The word Krimi was 
referred as infectious agent in Vedas, where 
Rakshyasa (drink blood), Yatudhana (cause pain), 
Pisacha (eats raw flesh), Apsara (swims in water) etc. 
have been described. Ancient Indian Classics 
described nearly hundred types of infectious agents. 
In Mahabharata Vedavyasa narrated that Krimi are 
everywhere and nobody can avoid them. It is also 
mentioned in classics that Mahamari (Communicable 
diseases) can spread from one person to another 
through air, water, animal, flies and physical contact. 
Ayurveda the oldest medical system described fever 
(Jvara) as a major disease in its Caraka Samhita. The 
symptoms of the COVID-19 may be correlated with 
the features of Sannipata Jwara described in 
Ayurvedic classics. However, In critical cases of 
COVID-19, it best matches with symptoms described 
for Sama Sannipata jwara. It comes under Janapada 
dhamsa vikara and can be grouped in Bhutabhisanga 
agantuga Vikara (External cause of microbes).  
Ayurveda principles observe life from outside to 
inside, from macro to micro, grade of diseases 
condition (Vyadhi bala) or from factors such as 
climate, constitution of patient (Prakruti), 
psychological influence (Satva), body symmetry 
(Samhanana), appetite (Ahara sakti) and physical 
strength (Vyayama Shakti). While understanding the 
etiology and pathogenesis of a disease involving 
biological agents like bacteria and viruses due 
attention may be given to immunity (Vyadhi 
kshyamatva) and self-recovery of the human system. 
Although there is no direct evidence of Ayurvedic 
medicine for COVID-19, some of the classical and 
herbal medications with proven immunomodulatory 
potential can be used as preventive medicines to 
counteract its symptoms.[15-20]  
Therefore, the primary aim of the study is to review of 
ancient classical literatures and past human treatment 
protocols of Ayurveda for prevention and treatment 
of infectious diseases and flu like illnesses, so as to 
provide guidance for the prevention of COVID-19. 
Presently, there are no comprehensive evidence 
based practice guidelines in Ayurveda to define the 
therapeutic option for COVID-19. Therefore, this study 
comprises consensus survey of Ayurveda practitioners 
on preventive measures and probable treatment 
option for asymptomatic, mild and moderate clinical 
conditions of COVID-19.  
MATERIALS AND METHODS 
Classical Ayurveda and recent modern literature with 
treatment protocols of Ayurveda for prevention and 
treatment of flu and infectious diseases were 
reviewed and COVID-19 has been categorized in four 
specific situations based on the severity of clinical 
condition. Four specific situations were described to 
the practitioners as 1) Ayurvedic Preventive measures 
including the Government declared options for 
apparently healthy individual having no sign and 
symptom of diseases;  2) High risk individuals those 
have co-morbidity factors like - COPD, Bronchitis, DM, 
heart diseases, chronic liver diseases (CLD), Immune 
suppression therapy and geriatric person/those 
having history of immigration to other country/who 
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declared self isolation or quarantine/pre-symptomatic 
phase patients; 3) Asymptomatic positive cases / 
Afebrile with only chills and respiratory symptoms in 
early stage of infection without dyspnea and 
hypoxemia; 4) Uncomplicated Corona-19 infected 
patients means febrile without dyspnea and 
hypoxemia. The Institutionally qualified Ayurveda 
practitioners and who are willing to participate in this 
survey were included in the working force. Total 110 
Ayurveda practitioners of different parts of India 
participated in the survey. These specific situations 
were conveyed and described to these participants 
and their opinions and options were collected through 
social media platform i.e. WhatsApp or SMS.  
RESULTS 
The information was asked from total 202 Ayurveda 
practitioners from different parts of India and only 
110 have participated in the survey, out of which 76 
participants (69%) are with post graduate degree in 
various disciplines of Ayurveda. Recommendation and 
suggestions received from more than 50% participants 
were taken into accounts to draft the 
recommendation for probable preventive and 
therapeutic regimen for the disease. Nitya Rasayana 
in form of Haridra milk or 10 ml of Cow ghee 
(Emulsified fat) with rice/roti, Chyawanprash Avaleha 
- 10g and Pranayama along with fumigation with 
Ayurvedic drugs were collectively recommended by all 
participants as Ayurvedic Preventive measures 
including the government declared options for 
apparently health individual who no sign and 
symptom of COVID-19 illness (Table 1). Nitya 
Rasayana  in form of Haridra milk  or 10 ml of Cow 
ghee (Emulsified fat) with rice/roti  and Gudduchi 
tablet/Samsamana Vati in recommended dose and 
along with fumigation were  recommended by all 
participants for High risk group/geriatric 
person/having history of immigration to other 
country/who declared self isolation or quarantine/ re-
symtometic phase patients (Table 2). Nitya Rasayana  
in form of Haridra milk - or 10 ml of Cow ghee 
(Emulsified fat ) with rice/roti  and Gudduchi tablet/ 
Samsamana Vati  in recommended dose and 
Sudarsana Ghana Vati in recommended dose were 
advised for all participants for  asymptomatic positive 
cases/Afebrile  with only chills and respiratory 
symptoms in early stage of infection without Dyspnea 
and hypoxemia patients (Table 3). Sudarsana Ghana 
Vati, Amrutadi Kasaya and Suvarna Vasanta Malati 
Rasa in its recommended doses were advised by all 
participants for Uncomplicated COVID -19 infected 
patients whose temperature > 370 c without dyspnea 
and hypoxemia (Table 4). 
Table 1: Ayurvedic preventive measures including 
the government declared options for apparently 




Dose No. of 
practitioners 
with positive 
response   
Decoction of  Sunthi, 
Lavang,  Pippali, 
Maricha, cinnamon 
bark, teja patra  
2 gm each in 200ml 
water  reduced to 50 
ml  
- 50 ml twice 
empty stomach  
75 
Haridra milk  or Cow 
ghee (Emulsified fat)- 
10 ml with rice/roti  
5 gm Haridra boiled in 
250 ml of milk and 
reduced to 200 ml 
110 
Chyawanprash Avaleha  10gm once  before 
break fast  
110 
Aswagadha tablet - 
250mg  
2 tab twice after food  59 
Amalaki Churna  10 gm at night along 
with Luke warm 
water 
67 
Dhopana of house by 
Resin of saal (Sarjja 
rasa), Neem leaves, 
coconut shell  and 
hingu 
Morning and evening  
Fumigation  
Smoke allergic 
patients should avoid 
110 
Pranayama  10-10 min twice  110 
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Morning and Evening  
Table 2: Ayurvedic preventive measures for High risk 
group/geriatric person/those have history of 
immigration to other country/who declared self-




Dose  No. of 
practitioners 
with positive 
response   
Sudarsana ghana vati -
250mg  
 2 tab twice daily 
after food  
75 
Gudduchi tablet / 
Samsamana Vati -
250mg  
2 tab twice after 
food 
110 
Nitya Rasayana Haridra 
milk  or Cow ghee( 
Emulsified fat ) - 10ml 
with rice/roti 
5 gm Haridra boiled 
in 250 ml of milk and 
reduced to 200 ml, 
Twice a daily 
110 
Chyawanprash Avaleha 
/ Fortified  Chauvan 
prash with Gold and 
silver particle  
10gm once  before 
break fast  
99 
Dhupana of house by 
Resin of saal (sarjja 
rasa), Neem leves, 
coconut shell  and 
hingu. 






Pranayama  10-10 min twice  100 
Table 3: Ayurvedic preventive measures for 
asymptomatic positive cases/Afebrile with only chills 
and respiratory symptoms in early stage of infection 




Dose No. of 
practitioners with 
positive response 




Samsamana Vati  
2 tab twice after 
food 
110 
Nitya Rasayana- 5 gm Haridra boiled 110 
Haridra milk  or Cow 
ghee (Emulsified fat) 
- 10 ml with rice/roti 
in 250 ml of milk 
and reduced to 200 
ml, Twice a daily 
Vyagri haritaki  10gm twice daily 
with luke warm 
water before food  
59 
Kusmanda Avaleha  10gm twice daily 
with luke warm 
water before food 
76 
Agathi haritaki  10gm twice daily 
with luke warm 
water before food 
62 
Bilvadi gulika -125mg  2 tab twice daily 
with luke warm 




1 tab with  2-4 drop 
of honey in mornig 
empty stomach  
78 
Kapha ketu rasa -125 
mg  
 2tabs with one 





2tabs with one 
spoon of fresh 
parijata leave  juice 
90 
Talisadi churna  10gm twice before 
with honey /luke 
warm water  
72 
Arogya vardhini Rasa 
-250 mg  
1 tablet –twice daily 
with water after 
food  
67 
Table 4: Ayurvedic preventive measures for 
uncomplicated COVID-19 infected patients having 




Dose  No. of 
practitioners 
with positive 
response   
Sudarsana ghana vati  2 tab twice daily after 
food 
110 
Amrutadi kasayam  20ml twice ith 20 ml 
luke warm water 
before food  
110 
Sanjeevani vati -125mg  1 tablet before food  80 
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Suvrnna Vasanta 
Malati Rasa -125mg  
 1tabs twice with one 
spoon of fresh 
parijata leave  juice 
110 
Sadanga Paneeya  Quantity sufficient as 




Rasa -60 mg tab  
 One tablet twice with 
honey when kapha 
predominant more  
65 
Vyagri haritaki  10gm twice daily with 
luke warm water 
before food  
99 
Ayush -64-250 mg cap  2 capsule twice with 
water 
66 
Agathi haritaki  10gm twice daily with 
luke warm water 
before food 
92 
Bilvadi gulika -125mg  2 tab twice daily with 
luke warm water 
before  food 
73 
Purna chandra Rasa 
125mg  
1 tab with  2-4 drop of 
honey in mornig 
empty stomach  
78 
Kapha ketu rasa -125 
mg  
 2tabs with one spoon 
of fresh tulsi juice  
82 
Saubhgya vati -125mg  2tabs with one spoon 
of fresh parijata leave  
juice 
90 
Talisadi churna  10gm twice before 
with honey /luke 
warm water  
72 
Arogya vardhini Rasa -
250 mg  
1 tablet –twice daily 
with water after food  
62 
DISCUSSION 
In present scenario, it is clear evident that spread of 
COVID-19 is unstoppable and it has infected more 
than 77,000 people and already taken lives of 2200 
people worldwide (as on 22 Feb 2020). Therefore, a 
coordinated global response between the health 
organizations with a collaborative and co-operative 
intention is the ultimate requirement to meet this 
unprecedented challenge of COVID-19. Sharing of 
medical advices, clinical data, investigations protocols, 
precautionary measures drugs and life saving 
equipments between the countries having experience 
of COVID-19 management will be very valuable 
lessons to pass on.  
In India, Ayurveda being the ancient medical science 
has a great importance in diseases management with 
its ultimate goal of ensure complete and 
comprehensive health i.e. Mental, physical and social 
and the classical literature of Ayurveda is all about 
maintaining the equilibrium status of the  of body 
tissues. As per Ayurveda the progression of any 
disease should be stopped at the earliest possible 
stage (Sanchaya & Prokapa). In case of infectious 
diseases, it is always advisable that stopping the 
further progression is the most ideal for  controlling 
the disease, and immunity whether innate or acquired 
should be increase by various means, which ultimately 
ensures, that even with the exposure of the infectious 
disease pathogens, disease is not going to be 
manifested in the body.  
In the present study, all Ayurveda Practitioners 
recommended Ayurveda medicines are classical, 
however Ayush-64 is research based formulation of 
CCRAS, which is widely used in malaria and different 
fever by Ayurveda practitioners. Most of the 
recommended formulations were also advised by 
Ministry of AYUSH. The decoction of Sunthi (Zingiber 
officinale Roscoe.), Lavanga (Syzygium aromaticum 
(L.) Merr. & L.M. Perry) and Maricha (Piper nigrum 
Linn.) advised in healthy person is not only provide 
humoral and cell mediated responses but also reduce 
the air way hyper responsiveness and nasal 
congestion.[21-23] Ayurveda  products and fatty acids in  
form of ghee are implicated in the up-regulation of 
immune function. They control the immune system in 
a pleiotropic manner and participate in various 
processes of the adaptive/innate immunity.[24] Haridra 
(Curcuma longa Linn.) has active constituent curcumin 
which blocks cytokine release, most importantly the 
key pro-inflammatory cytokines, interleukin-1, 
interleukin-6 and tumor necrosis factor-α, which is 
advisable to take with milk. The suppression of 
cytokine release by curcumin correlates with clinical 
improvement in experimental models of flu and 
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infectious diseases and can be compared with COVID-
19 where a cytokine storm plays a significant role in 
mortality.[25] Chauvan prasha has been demonstrated 
useful in treating respiratory problems, allergic cough 
and bronchitis, common cold and strengthens 
respiratory tract as immune-boosting agent.[26] 
Similarly, Sudarshana Ghana Vati is the derived 
formulation of Sudarsana churna which has good 
response in malarial fever and allegic rhinitis.[27] One 
of the recommended drug in the present consensus 
i.e. Gudduchi Tablet (Tinospora cordifolia (Willd.) 
Miers) is a potent immuno-modulator in viral 
infection.[28-29] Vasanta Malati Rasa is a well known 
Kharaliya Rasayana.[30] Parijata (Nyctanthes arbor-
tristis L.) is used to treat fever of all kind including 
malarial fever and have analgesic, anti-inflammatory, 
anti-viral, anti-bacterial, anti-spasmodic, anti-pyretic, 
anti-allergic, Anti-fungal, immuno-modulator, 
insecticidal, respiratory stimulant and anti-malarial 
properties.[31-33] Tulasi (Ocimum sanctum L.) is a good 
anti-viral agent even treating viral encephalitis.[34] 
Thus, the formulations of four different clinical 
situation recommended by all participant have ample 
scientific data in experimental model to satisfy its 
immune-modulator and antiviral activities in COVID-
19 management. The recommendations of Ayurvedic 
drugs received in this study for COVID-19 are on the 
basis of their personal experience and historical 
knowledge of the infectious diseases. These 
recommended drugs have established potential of 
immunity boosting which is the ultimate requirement 
to stop the spread of COVID-19 and can also be taken 
into consideration for its management along with 
modern drugs.  
CONCLUSION 
The results obtained in the study may provide a 
preventive strategy to the Ayurveda practitioners as 
well as common people across the globe by increasing 
the innate immunity of the body to combat COVID-19. 
For present, it appears inappropriate and premature 
to recommend any therapies for COVID-19, however, 
immunity of the healthy person and immune-
compromised can be enhanced with these 
recommended Ayurveda drugs to defend against the 
infection. However, till today, social distancing and 
sanitizations measures is considered as most effective 
way to stop the spread of COVID-19.  The ultimate 
requirement at this point is that Ayurveda or other 
medicine systems needs interdisciplinary research and 
should be performed in chorus with the researchers 
who can contribute to such research.  Further, pilot 
studies for different groups are recommended.   
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